Medicare GLP-1 bridge starts with $50 copay and tight eligibility rules
CMS has launched a temporary national Medicare program that offers some eligible Part D beneficiaries GLP-1 weight-loss drugs for $50 a month.
CMS has launched a temporary national Medicare program that offers some eligible Part D beneficiaries GLP-1 weight-loss drugs for $50 a month.
United States Federal Policy and Agency Actions – On June 23, 2026, DOJ announced charges against 455 defendants, alleging $6.5B+ in false claims for fraud and opioids.
CMS proposed a 2027 Medicare rule that would reduce payments for certain 340B-acquired drugs at hospital outpatient departments, with the agency saying the change could lower costs for some beneficiaries if finalized.
Federal prosecutors charged 13 North Texas defendants in seven cases, with most in the Dallas division, as part of a June 23 fraud sweep.
DOJ says its 2026 National Health Care Fraud Takedown charged 455 defendants tied to more than $6.5B in alleged false claims. The rollout is continuing.
A new June 11, 2026 GAO report warns U.S. debt is outpacing the economy, with net interest projected to reach nearly 10% of GDP by 2056.